Mostrar el registro sencillo del ítem

dc.contributor.authorMoreno-Torres, Víctor
dc.contributor.authorMartínez-Urbistondo, María
dc.contributor.authorCalderón-Parra, Jorge
dc.contributor.authorMills, Patricia
dc.contributor.authorMuñoz Serrano, Alejandro
dc.contributor.authorArias-Milla, Ana
dc.contributor.authorBenítez, Laura
dc.contributor.authorAguilar-Pérez, Myriam
dc.contributor.authorMúñez-Rubio, Elena
dc.contributor.authorRamos-Martínez, Antonio
dc.contributor.authorFernández-Cruz, Ana
dc.contributor.authorCuervas-Mons, Valentín
dc.contributor.authorde Mendoza, Carmen
dc.date2023
dc.date.accessioned2023-09-25T14:43:54Z
dc.date.available2023-09-25T14:43:54Z
dc.identifier.citationMoreno-Torres, V., Martínez-Urbistondo, M., Calderón-Parra, J., Mills, P., Muñoz-Serrano, A., Arias-Milla, A., ... & de Mendoza, C. (2023). COVID-19 in hospitalized solid organ transplant recipients in a nationwide registry study. International Journal of Infectious Diseases.es_ES
dc.identifier.issn1201-9712
dc.identifier.urihttps://reunir.unir.net/handle/123456789/15316
dc.description.abstractObjectives: Underlying immunodeficiency has been associated with worse clinical presentation and increased mortality in patients with COVID-19. We evaluated the mortality of solid organ transplant (SOT) recipients (SOTR) hospitalized in Spain due to COVID-19.Methods: Nationwide, retrospective, observational analysis of all adults hospitalized because of COVID-19 in Spain during 2020. Stratification was made according to SOT status. The National Registry of Hospital Discharges was used, using the International Classification of Diseases, 10th revision coding list.Results: Of the 117,694 adults hospitalized during this period, 491 were SOTR: kidney 390 (79.4%), liver 59 (12%), lung 27 (5.5%), and heart 19 (3.9%). Overall, the mortality of SOTR was 13.8%. After adjustment for baseline characteristics, SOTR was not associated with higher mortality risk (odds ratio [OR] = 0.79, 95% confidence interval [CI] 0.60-1.03). However, lung transplantation was an independent factor related to mortality (OR = 3.26, 95% CI 1.33-7.43), while kidney, liver, and heart transplantation were not. Being a lung transplant recipient was the strongest prognostic factor in SOT patients (OR = 5.12, 95% CI 1.8813.98).Conclusion: This nationwide study supports that the COVID-19 mortality rate in SOTR in Spain during 2020 did not differ from the general population, except for lung transplant recipients, who presented worse outcomes. Efforts should be focused on the optimal management of lung transplant recipients with COVID-19.& COPY; 2023 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/es_ES
dc.language.isoenges_ES
dc.publisherInternational Journal of Infectious Diseaseses_ES
dc.relation.ispartofseries;vol. 134
dc.relation.urihttps://www.ijidonline.com/article/S1201-9712(23)00629-X/fulltext#articleInformationes_ES
dc.rightsopenAccesses_ES
dc.subjectCOVID-19es_ES
dc.subjectSOTes_ES
dc.subjectLung transplantationes_ES
dc.subjectLymphomaes_ES
dc.subjectmortalityes_ES
dc.subjecthospitalizationes_ES
dc.subjectScopuses_ES
dc.subjectJCRes_ES
dc.titleCOVID-19 in hospitalized solid organ transplant recipients in a nationwide registry studyes_ES
dc.typeArticulo Revista Indexadaes_ES
reunir.tag~ARIes_ES
dc.identifier.doihttps://doi.org/10.1016/j.ijid.2023.06.007


Ficheros en el ítem

Thumbnail

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem